{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:59:41Z","timestamp":1790773181544,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuroscience.2026.02.011","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:53:19Z","timestamp":1771084399000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histone acetyltransferase HAT1 drives malignant progression in lower-grade glioma: reshaping the immune microenvironment and molecular mechanisms"],"prefix":"10.1016","volume":"615","author":[{"given":"Zhi","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"26","key":"10.1016\/j.neuroscience.2026.02.011_b0010","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-020-01643-6","article-title":"The application of histone deacetylases inhibitors in glioblastoma","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.011_b0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nmeth.1607","article-title":"A roadmap to generate renewable protein binders to the human proteome","volume":"8","author":"Colwill","year":"2011","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.011_b0030","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4161\/21645515.2014.979640","article-title":"Mechanisms and pathways of innate immune activation and regulation in health and cancer","volume":"10","author":"Cui","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8240015","article-title":"Silencing LINC00294 restores mitochondrial function and inhibits apoptosis of glioma cells under hypoxia via the miR-21-5p\/CASKIN1\/cAMP Axis","volume":"2021","author":"Dong","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0040","first-page":"332","article-title":"New concepts in the management of diffuse low-grade glioma: proposal of a multistage and individualized therapeutic approach","volume":"17","author":"Duffau","year":"2015","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.011_b0045","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1432-1033.2004.04162.x","article-title":"Chromatin dynamics at DNA replication, transcription and repair","volume":"271","author":"Ehrenhofer-Murray","year":"2004","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13046-019-1044-z","article-title":"Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer","volume":"38","author":"Fan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.011_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tig.2020.12.003","article-title":"Underappreciated roles of DNA polymerase \u03b4 in replication stress survival","volume":"37","author":"Fuchs","year":"2021","journal-title":"Trends Genet."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11060-019-03250-8","article-title":"Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas","volume":"144","author":"Fukuya","year":"2019","journal-title":"J. Neurooncol"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.011_b0065","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2026.02.011_b0070","first-page":"23","article-title":"Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation","volume":"750","author":"Gong","year":"2013","journal-title":"Mutat. Res."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.011_b0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","article-title":"PD-L1 degradation pathway and immunotherapy for cancer","volume":"11","author":"Gou","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0085","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1080\/21655979.2021.1972197","article-title":"CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry","volume":"12","author":"Hu","year":"2021","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.011_b0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3727\/096504016X14809827856524","article-title":"Histone acetyltransferase 1 promotes cell proliferation and induces cisplatin resistance in hepatocellular carcinoma","volume":"25","author":"Jin","year":"2017","journal-title":"Oncol. Res."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.02.011_b0095","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1093\/bioinformatics\/btaa658","article-title":"Differential gene set enrichment analysis: a statistical approach to quantify the relative enrichment of two gene sets","volume":"36","author":"Joly","year":"2021","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.011_b0100","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.21873\/anticanres.14622","article-title":"Role of oncogenes and tumor-suppressor genes in carcinogenesis: a review","volume":"40","author":"Kontomanolis","year":"2020","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0110","article-title":"Differential regulatory analysis based on coexpression network in cancer research","volume":"2016","author":"Li","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-021-03003-0","article-title":"BCL7A as a novel prognostic biomarker for glioma patients","volume":"19","author":"Liu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.011_b0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.02.011_b0130","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1074\/jbc.M117.819201","article-title":"Fascin1 suppresses RIG-I-like receptor signaling and interferon-\u03b2 production by associating with I\u03baB kinase \u220a (IKK\u220a) in colon cancer","volume":"293","author":"Matsumura","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.011_b0135","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.abb.2018.03.040","article-title":"Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells","volume":"646","author":"Miao","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11060-015-1910-2","article-title":"Management of patients with recurrence of diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline","volume":"125","author":"Nahed","year":"2015","journal-title":"J. Neurooncol"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.011_b0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/neuonc\/nox208","article-title":"Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143","volume":"20","author":"Omuro","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0155","doi-asserted-by":"crossref","unstructured":"L. Planells-Ferrer et al., MYCN repression of Lifeguard\/FAIM2 enhances neuroblastoma aggressiveness. Cell Death Dis. 5(9) (2014) e1401.","DOI":"10.1038\/cddis.2014.356"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.011_b0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/15592294.2020.1827723","article-title":"Recent insights into Histone Acetyltransferase-1: biological function and involvement in pathogenesis","volume":"16","author":"Poziello","year":"2021","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.011_b0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","article-title":"Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model","volume":"4","author":"Reardon","year":"2016","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114370","article-title":"Development of natural products for anti-PD-1\/PD-L1 immunotherapy against cancer","volume":"281","author":"Ri","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.740588","article-title":"FOXP3\/HAT1 axis controls treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.011_b0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3171\/JNS\/2008\/109\/11\/0835","article-title":"Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial","volume":"109","author":"Shaw","year":"2008","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/stem.5530110305","article-title":"Prognostic significance of oncogenes and tumor suppressor genes in human malignancy","volume":"11","author":"Spandidos","year":"1993","journal-title":"Stem Cells"},{"issue":"43","key":"10.1016\/j.neuroscience.2026.02.011_b0190","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.011_b0195","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41419-021-04118-4","article-title":"Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1\/EZH2 complex in pancreatic cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.011_b0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.011_b0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.imbio.2014.05.002","article-title":"Human macrophage polarization in vitro: maturation and activation methods compared","volume":"219","author":"Vogel","year":"2014","journal-title":"Immunobiology"},{"issue":"20","key":"10.1016\/j.neuroscience.2026.02.011_b0210","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-019-1085-3","article-title":"Challenges and potential of PD-1\/PD-L1 checkpoint blockade immunotherapy for glioblastoma","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.011_b0225","first-page":"3898","article-title":"RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma","volume":"7","author":"Xue","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.011_b0230","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11060-018-2911-8","article-title":"G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity","volume":"139","author":"Yang","year":"2018","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.011_b0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nchembio.495","article-title":"Identification of lysine succinylation as a new post-translational modification","volume":"7","author":"Zhang","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0240","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fgene.2020.00363","article-title":"Novel immune-related gene signature for risk stratification and prognosis of survival in lower-grade glioma","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuroscience.2026.02.011_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588552","article-title":"PD-L1-mediated immunosuppression in glioblastoma is associated with the infiltration and M2-polarization of tumor-associated macrophages","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Immunol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:25:13Z","timestamp":1790771113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"alternative-id":["S0306452226001004"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.011","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone acetyltransferase HAT1 drives malignant progression in lower-grade glioma: reshaping the immune microenvironment and molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}